🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study compares insulin 287 (a possible new medicine) to insulin glargi...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2019-05-09
Trial ID
NCT03922750
Treatments Being Tested
This study will look at how insulin 287 works, if it is safe and the side e...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2018-12-07
Trial ID
NCT03766854
Treatments Being Tested
This trial is conducted in Europe. The aim of this first human dose trial i...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2013-03-04
Trial ID
NCT01809184
Treatments Being Tested
This trial is conducted in Europe. The aim of the trial is to investigate t...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2014-05-26
Trial ID
NCT02148861
Treatments Being Tested
This study compares the new long-acting insulin 287 with the marketed insul...
Status
Completed
Location
Profil Institut für Stoffwechselforschung GmbH
Start Date
2018-11-29
Trial ID
NCT03723772
Treatments Being Tested
This study will be conducted to look at the effect of decreased kidney func...
Status
Completed
Location
Charité Research Organisation GmbH
Start Date
2018-11-09
Trial ID
NCT03723785
Treatments Being Tested
The study will look at how insulin 287 and semaglutide work in the body, bo...
Status
Completed
Location
Profil Institut für Stoffwechselforschung GmbH
Start Date
2019-01-17
Trial ID
NCT03789578
Treatments Being Tested
This trial is conducted in Europe. The aim of the trial is to investigate t...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2016-11-15
Trial ID
NCT02964104
Treatments Being Tested
The study compares 2 medicines for people with type 2 diabetes: insulin 287...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2018-11-29
Trial ID
NCT03751657
This study compares insulin 287 (a possible new medicine) to insulin glargi...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2019-05-09
Trial ID
NCT03951805
Treatments Being Tested